LeonaBio (LONA) Receivables - Other (2019 - 2024)

LeonaBio (LONA) has 6 years of Receivables - Other data on file, last reported at $1.6 million in Q3 2024.

• Receivables - Other for Q3 2024 came in at $1.6 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was $1.6 million (changed N/A YoY), and the FY2023 annual result was $1.6 million, up 32.68% from the prior year.
• Receivables - Other held at $1.6 million in Q3 2024 per LONA's latest filing, from $1.6 million in the prior quarter.
• Over five years, Receivables - Other peaked at $2.9 million in Q1 2021 and troughed at $1.2 million in Q4 2022.
• A 5-year average of $1.9 million and a median of $1.7 million in 2022 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2020 and 2022: Receivables - Other soared 3511.11% in 2020, then slumped 47.47% in 2022.
• A 5-year view of Receivables - Other shows it stood at $1.3 million in 2020, then soared by 79.69% to $2.3 million in 2021, then slumped by 47.47% to $1.2 million in 2022, then jumped by 32.68% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024.
• Business Quant data shows LONA's Receivables - Other at $1.6 million in Q3 2024, $1.6 million in Q2 2024, and $1.6 million in Q1 2024.